Vertex Pharmaceutical (VRTX)

Company Overview
Vertex Pharmaceuticals Incorporated engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide. Its products include telaprevir, a Phase IIb clinical trial product for the treatment of hepatitis C virus infection; VX-702, a Phase II clinical trial product for rheumatoid arthritis and other inflammatory diseases; VX-770, a Phase I clinical trial product for cystic fibrosis; and VX-883, a preclinical stage product for bacterial infection. The company also offers Lexiva/Telzir for the treatment of HIV infection and AIDS under the collaboration with GlaxoSmithKline, as well as develops MK-0457 and MK-6592, which are in...
read more
Get Adobe Flash player

QUOTE

As of 03:03PM EDT May 25, 2012
Quote

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: -
Mailing Address: Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000 VERTEX PHARMACEUTICALS INC / MA CIK #: 0000875320 (see all company filings) SIC : 2834 - PHARMACEU
Phone: 617-444-6100
Fax: 617-576-2109
Website: http://www.vrtx.com

Company Details:

Symbol: VRTX
SIC: -
State location: MA
Sector: -
State of Inc: MA
Employees: 1422
Type: NASDAQ

Key executives:

Name Age Position
Ian F. Smith Cpa Aca 46 Chief Financial Officer and Exec. VP
Joshua S. Boger Ph.d. 60 Founder, Chief Exec. Officer, Pres
Kenneth S. Boger 65 Sr. VP, Sec. and Gen. Counsel
Peter Mueller Ph.D. 55 Chief Scientific Officer, Exec. VP of Drug Innovation & Realization and Member of Scientific Advisory Board
Victor A. Hartmann M.D. 62 Exec. VP of Strategic and Corp. Devel.

VERTEX PHARMACEUTICAL (VRTX) MESSAGE BOARD

Post # Subject Re Name Date
1 At the moment, the stock has changed its... 0
2 Here on this message board we are inviting... 0
Get Adobe Flash player